[Therapy of porphyria cutanea tarda through metabolic alkalization with uralyt-U].
D000328:Adult; D000368:Aged; D002951:Citrates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011162:Porphobilinogen / Q000032:analysis; D011164:Porphyrias / Q000188:drug therapy*; D011166:Porphyrins / Q000032:analysis; D011188:Potassium / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy; D012964:Sodium / Q000627:therapeutic use*
D002951:Citrates; D011166:Porphyrins; D011162:Porphobilinogen; D012964:Sodium; D011188:Potassium
Behandlung der Porphyria cutanea tarda durch metabolische alkalisierung mit Uralyt-.